<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03577327</url>
  </required_header>
  <id_info>
    <org_study_id>ICLP10302017</org_study_id>
    <nct_id>NCT03577327</nct_id>
  </id_info>
  <brief_title>The Gut and Skin Microbiome in Vitiligo Disease Progression</brief_title>
  <official_title>The Gut and Skin Microbiome in Vitiligo Disease Progression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators plan to perform a pilot study that aims to characterize the microbiome of human
      vitiligo patients with both active and stable disease and compare this to the microbiome of
      age and sex matched controls. The investigators aim to answer the question whether the gut
      and skin microbiome of patients with vitiligo differs from the general population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 30, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiome composition</measure>
    <time_frame>12 months</time_frame>
    <description>Diversity analysis of microbiome samples in control subjects versus vitiligo subjects (measured by number of bacteria species/sample)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease Progression</measure>
    <time_frame>12 months</time_frame>
    <description>Disease progression in control subjects versus vitiligo subjects (measured by VASI score (0-100)).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diet History Food Frequencies</measure>
    <time_frame>12 months</time_frame>
    <description>Scoring from diet history food frequency questionnaires (measured by average daily food frequency scores).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vitiligo</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Adults with vitiligo</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy adults</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with or without vitiligo who are under the age of 90 years old.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with and/or without vitiligo lesional expansion over the past year.

          -  Age/sex-matched controls who do not have a diagnosis of vitiligo

          -  Subjects who are age 18-89 years of age at time of enrollment

          -  Subjects who are able and willing to give informed consent for this study and the
             Dermatology Tissue Acquisition and Biorepository (STU00009443)

        Exclusion Criteria:

          -  Subjects who are younger than 18 years of age or 90 years of age or older

          -  Subjects who are unable to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I. Caroline Le Poole</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dermatology CTU</last_name>
    <phone>312-503-5944</phone>
    <email>NUdermatologyCTU@northwestern.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dermatology CTU</last_name>
      <phone>312-503-5944</phone>
      <email>NUdermatologyCTU@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 2, 2018</study_first_submitted>
  <study_first_submitted_qc>July 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2018</study_first_posted>
  <last_update_submitted>June 2, 2019</last_update_submitted>
  <last_update_submitted_qc>June 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>I Caroline Le Poole</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitiligo</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

